Compare ALRS & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALRS | MRVI |
|---|---|---|
| Founded | 1879 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 536.4M | 449.6M |
| IPO Year | 2019 | 2020 |
| Metric | ALRS | MRVI |
|---|---|---|
| Price | $23.41 | $3.91 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 7 |
| Target Price | ★ $25.00 | $4.57 |
| AVG Volume (30 Days) | 111.3K | ★ 1.3M |
| Earning Date | 01-27-2026 | 02-24-2026 |
| Dividend Yield | ★ 3.60% | N/A |
| EPS Growth | ★ 1114.87 | N/A |
| EPS | ★ 1.95 | N/A |
| Revenue | ★ $275,452,000.00 | $192,435,000.00 |
| Revenue This Year | $43.58 | N/A |
| Revenue Next Year | $3.26 | $9.04 |
| P/E Ratio | $11.95 | ★ N/A |
| Revenue Growth | ★ 67.44 | N/A |
| 52 Week Low | $15.78 | $1.67 |
| 52 Week High | $24.33 | $6.21 |
| Indicator | ALRS | MRVI |
|---|---|---|
| Relative Strength Index (RSI) | 63.65 | 64.23 |
| Support Level | $21.53 | $3.19 |
| Resistance Level | $23.90 | $3.37 |
| Average True Range (ATR) | 0.52 | 0.18 |
| MACD | 0.04 | 0.03 |
| Stochastic Oscillator | 79.75 | 84.85 |
Alerus Financial Corp is a financial holding company registered in the United States. The company operates in four segments: Banking, Retirement & Benefit Services, Wealth Management, and Mortgage. It provides various banking services such as checking, debit cards, savings, current deposits, loans and advances, online banking, mobile banking, private banking, payment solutions, and other business products. Additionally, the company provides mortgage loans, retirement planning solutions, individual retirement accounts, retirement plan advisory services as well as wealth management services, including financial & estate planning, trust, and fiduciary services. The company's revenue mainly consists of interest income, commission, management fees, and other income.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.